Elanco Animal Health (ELAN) Net Margin (2017 - 2026)

Elanco Animal Health has disclosed Net Margin across 10 years of filings, most recently posting 4.16% for Q1 2026.

• Net Margin for Q1 2026 came in at 4.16%, down 146.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.95% (down 1337.0% YoY), and the FY2025 annual result was 4.92%, down 1253.0% from the prior year.
• Net Margin came in at 4.16% for Q1 2026 at Elanco Animal Health, up from 24.13% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 35.34% in Q3 2024 to a low of 102.62% in Q3 2023.
• The 5-year median for Net Margin is 0.85% (2022), against an average of 6.42%.
• Across the five-year window, Net Margin plunged 9629 bps in 2023 and surged 13796 bps in 2024, its largest moves.
• Elanco Animal Health's Net Margin stood at 5.48% in 2022, then plunged by 148 bps to 13.62% in 2023, then surged by 94 bps to 0.78% in 2024, then sank by 2976 bps to 24.13% in 2025, then surged by 117 bps to 4.16% in 2026.
• The last three Net Margin figures came in at 4.16% (Q1 2026), 24.13% (Q4 2025), and 2.99% (Q3 2025), per Business Quant data.